Unknown

Dataset Information

0

Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.


ABSTRACT: Development of a Plasmodium falciparum (Pf) transmission blocking vaccine (TBV) has the potential to significantly impact malaria control. Antibodies elicited against sexual stage proteins in the human bloodstream are taken up with the blood meal of the mosquitoes and inactivate parasite development in the mosquito. In a phase 1 trial, a leading TBV identified as Pfs25-EPA/Alhydrogel® appeared safe and immunogenic, however, the level of Pfs25-specific antibodies were likely too low for an effective vaccine. Pfs230, a 230-kDa sexual stage protein expressed in gametocytes is an alternative vaccine candidate. A unique 6-cysteine-rich domain structure within Pfs230 have thwarted its recombinant expression and characterization for clinical evaluation for nearly a quarter of a century. Here, we report on the identification, biochemical, biophysical, and immunological characterization of recombinant Pfs230 domains. Rabbit antibodies generated against recombinant Pfs230 domains blocked mosquito transmission of a laboratory strain and two field isolates using an ex vivo assay. A planned clinical trial of the Pfs230 vaccine is a significant step toward the potential development of a transmission blocking vaccine to eliminate malaria.

SUBMITTER: MacDonald NJ 

PROVIDER: S-EPMC5025679 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.

MacDonald Nicholas J NJ   Nguyen Vu V   Shimp Richard R   Reiter Karine K   Herrera Raul R   Burkhardt Martin M   Muratova Olga O   Kumar Krishan K   Aebig Joan J   Rausch Kelly K   Lambert Lynn L   Dawson Nikiah N   Sattabongkot Jetsumon J   Ambroggio Xavier X   Duffy Patrick E PE   Wu Yimin Y   Narum David L DL  

The Journal of biological chemistry 20160718 38


Development of a Plasmodium falciparum (Pf) transmission blocking vaccine (TBV) has the potential to significantly impact malaria control. Antibodies elicited against sexual stage proteins in the human bloodstream are taken up with the blood meal of the mosquitoes and inactivate parasite development in the mosquito. In a phase 1 trial, a leading TBV identified as Pfs25-EPA/Alhydrogel® appeared safe and immunogenic, however, the level of Pfs25-specific antibodies were likely too low for an effect  ...[more]

Similar Datasets

| S-EPMC10105769 | biostudies-literature
| S-EPMC6973022 | biostudies-literature
| S-EPMC1224620 | biostudies-literature
| S-EPMC5733390 | biostudies-literature
| S-EPMC7886318 | biostudies-literature
2017-11-16 | GSE104114 | GEO
| S-EPMC4808191 | biostudies-literature
| S-EPMC5646874 | biostudies-literature
| S-EPMC2409366 | biostudies-literature
| S-EPMC7577739 | biostudies-literature